Estimating the risk of recurrence in neoadjuvant-treated breast cancer patients
Enter the values of pre-NAT features to estimate the relative risk of recurrence.
Cumulated relative risk
Estimated risk:
Please fill out the form to receive a risk assessment.
The calculator is based on retrospective data of 257 women diagnosed with primary invasive breast carcinoma treated with NAT at Turku University Hospital Expert Responsibility Area, Finland, during 2010–2020 (Korpinen et al. doi: xxxx).
No data is collected or stored.